Approach to Medical Management of Obesity

ONLINEAMAEnduring Material



Date & Location
Sunday, August 14, 2022, 12:00 AM - Monday, August 14, 2023, 12:00 PM

Overview

This online lecture provides physicians and other healthcare practitioners updates on current issues related to healthcare. The lecture will be maximum of one hour in length, followed by post test. Participants will have the opportunity to learn to evaluate patients presenting for management of obesity, apply their knowledge of lifestyle interventions for weight management & assess the benefits and risks of weight loss pharmacotherapies.

Release Date: August 14, 2022
End Date: August 14, 2023


Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Researchers, Students

Overall Learning Objective
  1. Evaluate patients presenting for management of obesity
  2. Apply their knowledge of lifestyle interventions for weight management
  3. Assess the benefits and risks of weight loss pharmacotherapies

Registration
FREE of charge

Accreditation

The Ministry of Public Health's Department of Healthcare Professions (DHP) considers Asynchronous activities under Category 2 as self-directed learning.  

 
Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to the Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Bibliography:

Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL. Obesity pathogenesis: an endocrine society scientific statement. Endocrine reviews. 2017 Aug 1;38(4):267-96.

Fitch AK, Bays HE. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars. 2022 Mar 1;1:100004.

Ryan DH, Yockey SR. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017 Jun;6(2):187-194. doi: 10.1007/s13679-017-0262-y. PMID: 28455679; PMCID: PMC5497590.

Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Pharmacological management of obesity: an endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2015 Feb 1;100(2):342-62

Saunders KH, Igel LI, Shukla AP, Aronne LJ. Drug-induced weight gain: rethinking our choices. Journal of Family Practice. 2016 Nov 1;65(11):780-7.

 

Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American college of cardiology. 2014 Jul 1;63(25 Part B):2985-3023.